Log In
Print
BCIQ
Print
Print this Print this
 

LNA-antimiR, miravirsen (SPC3649)

  Manage Alerts
Collapse Summary General Information
Company Santaris Pharma A/S
DescriptionLocked nucleic acid (LNA)-modified phosphorothioate anti-sense oligonucleotide targeting microRNA-122 (miR-122)
Molecular Target MicroRNA-122 (miR-122)
Mechanism of ActionAntiviral agent
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat HCV infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today